Trince announces distributor agreement with Meiwafosis
This strategic partnership will significantly bolster our presence in Japan, a global hub for stem cell research and therapies, particularly iPSCs.
By joining forces with Meiwafosis, we aim to expand our commercial footprint and provide Japanese researchers with access to our innovative cell transfection technologies. This collaboration will make cell engineering more gentle and effective, empowering groundbreaking advancements in the field.
Stay tuned for more updates as we embark on this exciting journey together!
Nature Spinoff Prize
Trince, a spin-off from Ghent University, has won the prestigious Nature Spinoff Prize from the scientific journal Nature. This award, which is awarded globally, recognizes spin-offs that translate original, high-quality scientific research into products and services that address market problems and have a positive impact on society. In the final, Trince eventually beat two American and one British opponent.
The EOS is a well-known magazine in Belgium and The Netherlands for popular science. (Dutch only).
Ziektes behandelen met fotoporatie: ‘Je wilt iets in de
cel brengen, maar die tegelijkertijd zo gezond mogelijk
achterlaten’
UGent spin-off nominated for prestigious Nature Spinoff Prize
Trince, an innovative spin-off from Ghent University, is one of four finalists for the global Spinoff Prize from the scientific journal Nature.
This prestigious award is given to spin-offs that translate original, high-quality scientific research into products and services that address market problems and have a positive impact on society. Trince has been nominated for its groundbreaking research into photoporation, a new and safer method of introducing DNA and other molecules into cells, such as in immunotherapy or gene therapy.
The word is out
Very proud to announce that TrinceBio is longlisted for the Nature Spinoff Prize!We are working hard on our non-viral cell engineering platform and are happy to receive recognition for the potential and way forward of our technology.
European Innovation Council Awards
European Innovation Council Awards €2.5 Million Grant to Trince, NecstGen, and IBSAL for Advancing Cell Therapy Manufacturing
The HealthTech Investor Summit
Philip Mathuis pitched on the HealthTech Investor Summit !
Highly Cited Researcher
Our CSO Professor Kevin Braeckmans is again on this year’s Clarivate list of highly cited researchers. We are proud.
Advancing Cell Therapy: Photothermal nanofibers enable macromolecule delivery in unstimulated human T cells
In the pursuit of refining adoptive T cell transfer, a critical facet of cell therapies, a recent study Ghent University delves into the application of Photothermal Electrospun Nanofibers (PEN) for intracellular delivery. This technique has proven efficient for activated T cells and now presents a promising avenue for unstimulated T cells.
Photoporation: a promising strategy for the generation of CAR-NK cells
Another milestone achieved by Charlotte Hinnekens from Ghent University who was able to generate CAR-NK cells by using photoporation.
Reach out if you wish to know more about the technology used. info@trincebio.com